DRUG INNOVATION & DESIGN INC has a total of 24 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and micro-structure and nano-technology are ROTOP PHARMAKA GMBH, ILEX PRODUCTS INC and STARKS ASS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Australia | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Special acyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Nanostructure applications | |
#5 | Sugars | |
#6 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Glazier Arnold | 24 |
#2 | Yanachkov Ivan | 6 |
#3 | Yanachkova Milka | 6 |
Publication | Filing date | Title |
---|---|---|
US2003031677A1 | Exponential pattern recognition based cellular targeting, compositions, methods and anticancer applications | |
US2001012893A1 | Acyclovir diester derivatives | |
CA2391534A1 | Selective cellular targeting: multifunctional delivery vehicles | |
WO0136003A2 | Selective cellular targeting: multifunctional delivery vehicles | |
EP1255567A1 | Selective cellular targeting: multifunctional delivery vehicles | |
WO9851692A1 | Acyclovir diester derivatives | |
US5789589A | Guanine analog phosphates | |
US5659061A | Tumor protease activated prodrugs of phosphoramide mustard analogs with toxification and detoxification functionalities | |
US5627165A | Phosphorous prodrugs and therapeutic delivery systems using same |